Table 1. . Chemotherapy regimens.
First-line options: | |
FLOT | Oxaliplatin 85 mg/m2 i.v. on day 1 Docetaxel 50 mg/m2 i.v. on day 1 Leucovorin 200 mg/m2 i.v. on day 1 Fluorouracil 2600 mg/m2 continuous infusion over 24 h daily on day 1 Every 14 days |
FOLFOX | Oxaliplatin 85 mg/m2 i.v. on day 1 Leucovorin 400 mg/m2 i.v. on day 1 Fluorouracil 400 mg/m2 i.v. push on day 1 Fluorouracil 1200 mg/m2 continuous infusion over 24 h daily on days 1 and 2 Every 14 days |
Second-line options: | |
FOLFIRI | Irinotecan 180 mg/m2 i.v. on day 1 Leucovorin 400 mg/m2 i.v. on day 1 Fluorouracil 400 mg/m2 i.v. push on day 1 Fluorouracil 1200 mg/m2 continuous infusion over 24 h daily on days 1 and 2 Every 14 days |
FOLFIRINOX | Oxaliplatin 85 mg/m2 i.v. on day 1 Irinotecan 150 mg/m2 i.v. on day 1 Leucovorin 200 mg/m2 i.v. on day 1 Fluorouracil 1200 mg/m2 continuous infusion over 24 h daily on days 1 and 2 Every 14 days |
Paclitaxel with carboplatin | Paclitaxel 200 mg/m2 i.v. on day 1 Carboplatin AUC 5 i.v. on day 1 Every 21 days |
Paclitaxel | Paclitaxel 80 mg/m2 i.v. on days 1, 8, 15 Every 28 days |
Docetaxel and irinotecan† | Docetaxel 35 mg/m2 i.v. on days 1 and 8 Irinotecan 50 mg/m2 i.v. on days 1 and 8 Every 21 days |
Docetaxel 75 mg/m2 i.v. on day 1 Every 21 days | |
Docetaxel 150 mg/m2 i.v. on day 1 Every 14 days | |
Additional therapy options: | |
Nivolumab‡ | 240 mg i.v. on day 1 every 14 days, or 360 mg i.v. on day 1 every 21 days, or 480 mg i.v. on day 1 every 28 days |
Pembrolizumab‡ | 200 mg i.v. on day 1 every 21 days, or 400 mg i.v. on day 1 every 42 days |
Alone or combined.
Alone or when added to a regimen above.
AUC: Area under the curve; FLOT: 5FU, leucovorin, oxaliplatin and docetaxel; h: Hour; i.v.: Intravenously.